BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37888115)

  • 1. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.
    López L; Fernández-Vañes L; Cabal VN; García-Marín R; Suárez-Fernández L; Codina-Martínez H; Lorenzo-Guerra SL; Vivanco B; Blanco-Lorenzo V; Llorente JL; López F; Hermsen MA
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinonasal Carcinomas with Neuroendocrine Features: Histopathological Differentiation and Treatment Outcomes.
    Soldatova L; Campbell RG; Carrau RL; Prevedello DM; Wakely P; Otto BA; Filho LF
    J Neurol Surg B Skull Base; 2016 Dec; 77(6):456-465. PubMed ID: 27857871
    [No Abstract]   [Full Text] [Related]  

  • 3. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
    Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
    Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profiling of poorly differentiated sinonasal tumours.
    López-Hernández A; Vivanco B; Franchi A; Bloemena E; Cabal VN; Potes S; Riobello C; García-Inclán C; López F; Llorente JL; Hermsen M
    Sci Rep; 2018 Mar; 8(1):3998. PubMed ID: 29507386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
    Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
    Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma.
    Smith SR; Som P; Fahmy A; Lawson W; Sacks S; Brandwein M
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1617-22. PubMed ID: 11037813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of
    Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
    J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
    Abdelmeguid AS; Bell D; Hanna EY
    Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
    Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
    Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between
    Felix-Ravelo M; Bey A; Arous F; Paris-Grandpierre S; Jankowski R; Nguyen DT
    Acta Otolaryngol; 2017 Feb; 137(2):191-195. PubMed ID: 27576899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
    van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
    Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH2 -Mutated Sinonasal Tumors: A Review.
    Alzumaili B; Sadow PM
    Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
    Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
    Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
    Bellizzi AM; Bourne TD; Mills SE; Stelow EB
    Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
    Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
    Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
    Ejaz A; Wenig BM
    Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
    Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
    J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma?
    Haas I; Ganzer U
    Onkologie; 2003 Jun; 26(3):261-7. PubMed ID: 12845211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.